会社概要
- 正式社名: Divis Laboratories Limited
- 登録国: India
- 住所: 1-72/23 (P)/DIVIS/303, Cyber Hills, Gachibowli,, Hyderabad
- 従業員数: 5000 名以上
説明:
Established in 1990, Divi's Laboratories is among the world's largest API manufacturers, with about $1.3 billion in revenue and exports to more than 100 countries. The company specializes in generic APIs, nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovators, primarily serving regulated markets in the US and Europe, operating 3 state-of-the-art facilities with a team of more than 21,000 people committed to sustainable, innovative and reliable manufacturing.
事業活動
原薬(API)
製造業者受託製造業者(CMO)原薬メーカー
受託・アウトソーシングサービス
製造業者受託製造業者(CMO)原薬メーカー
先発品原薬
製造業者受託製造業者(CMO)原薬メーカー
主要製品/サービス
- 原薬(API): gabapentin, Phenylephrine Hcl, Losartan, Pregabalin, Irbesartan, Dextromethorphan Base, Levetiracetam, Carbidopa, Diltiazem HCL, Levodopa, Valacyclovir HCL, Valsartan, Iopamidol, Venlafaxine HCL, Proguanil HCL, Quetiapine Fumarate, Nabumetone, Naproxen
- 受託・アウトソーシングサービス: API Contract manufacturing/CDMO/CMO
当社の製品・サービス
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
認証
FDA
GMP
ISO
証明
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す